APO Research
Talk to an analyst

APO RESEARCH · REPORT

Burosumab

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Burosumab Industry Growth and Trends Forecast to 2032

29 December 202572 pages

Choose your research edition.

Industry ResearchBurosumab Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Burosumab Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Burosumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Burosumab Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Burosumab Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Burosumab market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Burosumab is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Burosumab is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Burosumab is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Burosumab include Ultragenyx and Kyowa Kirin Co.,Ltd. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Burosumab market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Burosumab market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Burosumab market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Burosumab.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Burosumab market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Burosumab Market by Company

Ultragenyx

Kyowa Kirin Co.,Ltd.

Burosumab Segment by Type

10mg/mL

20mg/mL

30mg/mL

Burosumab Segment by Application

Minor Patients Over 1 Year Old

Adult Patients

Burosumab Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Burosumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Burosumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Burosumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Burosumab manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Burosumab in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg/mL Table 2. Major Company of 20mg/mL Table 3. Major Company of 30mg/mL Table 4. Global Burosumab Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Burosumab Sales by Type (2021-2026) & (K Units) Table 6. Global Burosumab Sales Market Share in Volume by Type (2021-2026) Table 7. Global Burosumab Sales by Type (2021-2026) & (US$ Million) Table 8. Global Burosumab Sales Market Share in Value by Type (2021-2026) Table 9. Global Burosumab Price by Type (2021-2026) & (US$/Unit) Table 10. Global Burosumab Sales by Type (2027-2032) & (K Units) Table 11. Global Burosumab Sales Market Share in Volume by Type (2027-2032) Table 12. Global Burosumab Sales by Type (2027-2032) & (US$ Million) Table 13. Global Burosumab Sales Market Share in Value by Type (2027-2032) Table 14. Global Burosumab Price by Type (2027-2032) & (US$/Unit) Table 15. North America Burosumab Sales by Type (2021-2026) & (K Units) Table 16. North America Burosumab Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Burosumab Sales by Type (2021-2026) & (K Units) Table 18. Europe Burosumab Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Burosumab Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Burosumab Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Burosumab Sales by Type (2021-2026) & (K Units) Table 22. Latin America Burosumab Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Burosumab Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Burosumab Sales by Type (2021-2026) & (US$ Million) Table 25. Burosumab Industry Trends Table 26. Burosumab Industry Drivers Table 27. Burosumab Industry Opportunities and Challenges Table 28. Burosumab Industry Restraints Table 29. Global Burosumab Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Burosumab Revenue Market Share by Company (2021-2026) Table 31. Global Burosumab Sales by Company (2021-2026) & (K Units) Table 32. Global Burosumab Sales Share by Company (2021-2026) Table 33. Global Burosumab Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Burosumab Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Burosumab Major Company Production Sites and Headquarters Table 36. Global Burosumab Company, Product Type & Application Table 37. Global Burosumab Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Burosumab by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Burosumab Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Burosumab Sales by Region (2021-2026) & (K Units) Table 42. Global Burosumab Sales Market Share in Volume by Region (2021-2026) Table 43. Global Burosumab Sales by Region (2021-2026) & (US$ Million) Table 44. Global Burosumab Sales Market Share in Value by Region (2021-2026) Table 45. Global Burosumab Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Burosumab Sales by Region (2027-2032) & (K Units) Table 47. Global Burosumab Sales Market Share in Volume by Region (2027-2032) Table 48. Global Burosumab Sales by Region (2027-2032) & (US$ Million) Table 49. Global Burosumab Sales Market Share in Value by Region (2027-2032) Table 50. Global Burosumab Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Burosumab Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Burosumab Sales by Application (2021-2026) & (K Units) Table 53. Global Burosumab Sales Market Share in Volume by Application (2021-2026) Table 54. Global Burosumab Sales by Application (2021-2026) & (US$ Million) Table 55. Global Burosumab Sales Market Share in Value by Application (2021-2026) Table 56. Global Burosumab Price by Application (2021-2026) & (US$/Unit) Table 57. Global Burosumab Sales by Application (2027-2032) & (K Units) Table 58. Global Burosumab Sales Market Share in Volume by Application (2027-2032) Table 59. Global Burosumab Sales by Application (2027-2032) & (US$ Million) Table 60. Global Burosumab Sales Market Share in Value by Application (2027-2032) Table 61. Global Burosumab Price by Application (2027-2032) & (US$/Unit) Table 62. North America Burosumab Sales by Application (2021-2026) & (K Units) Table 63. North America Burosumab Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Burosumab Sales by Application (2021-2026) & (K Units) Table 65. Europe Burosumab Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Burosumab Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Burosumab Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Burosumab Sales by Application (2021-2026) & (K Units) Table 69. Latin America Burosumab Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Burosumab Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Burosumab Sales by Application (2021-2026) & (US$ Million) Table 72. Ultragenyx Company Information Table 73. Ultragenyx Business Overview Table 74. Ultragenyx Burosumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Ultragenyx Burosumab Product Portfolio Table 76. Ultragenyx Recent Development Table 77. Kyowa Kirin Co.,Ltd. Company Information Table 78. Kyowa Kirin Co.,Ltd. Business Overview Table 79. Kyowa Kirin Co.,Ltd. Burosumab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Kyowa Kirin Co.,Ltd. Burosumab Product Portfolio Table 81. Kyowa Kirin Co.,Ltd. Recent Development Table 82. North America Burosumab Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 83. North America Burosumab Sales by Country (2021-2026) & (K Units) Table 84. North America Burosumab Sales Market Share by Country (2021-2026) Table 85. North America Burosumab Sales Forecast by Country (2027-2032) & (K Units) Table 86. North America Burosumab Sales Market Share Forecast by Country (2027-2032) Table 87. North America Burosumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 88. North America Burosumab Market Size by Country (2021-2026) & (US$ Million) Table 89. North America Burosumab Market Share by Country (2021-2026) Table 90. North America Burosumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 91. North America Burosumab Market Share Forecast by Country (2027-2032) Table 92. Europe Burosumab Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. Europe Burosumab Sales by Country (2021-2026) & (K Units) Table 94. Europe Burosumab Sales Market Share by Country (2021-2026) Table 95. Europe Burosumab Sales Forecast by Country (2027-2032) & (K Units) Table 96. Europe Burosumab Sales Market Share Forecast by Country (2027-2032) Table 97. Europe Burosumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. Europe Burosumab Market Size by Country (2021-2026) & (US$ Million) Table 99. Europe Burosumab Market Share by Country (2021-2026) Table 100. Europe Burosumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. Europe Burosumab Market Share Forecast by Country (2027-2032) Table 102. Asia-Pacific Burosumab Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Asia-Pacific Burosumab Sales by Country (2021-2026) & (K Units) Table 104. Asia-Pacific Burosumab Sales Market Share by Country (2021-2026) Table 105. Asia-Pacific Burosumab Sales Forecast by Country (2027-2032) & (K Units) Table 106. Asia-Pacific Burosumab Sales Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Burosumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Burosumab Market Size by Country (2021-2026) & (US$ Million) Table 109. Asia-Pacific Burosumab Market Share by Country (2021-2026) Table 110. Asia-Pacific Burosumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Asia-Pacific Burosumab Market Share Forecast by Country (2027-2032) Table 112. Latin America Burosumab Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Latin America Burosumab Sales by Country (2021-2026) & (K Units) Table 114. Latin America Burosumab Sales Market Share by Country (2021-2026) Table 115. Latin America Burosumab Sales Forecast by Country (2027-2032) & (K Units) Table 116. Latin America Burosumab Sales Market Share Forecast by Country (2027-2032) Table 117. Latin America Burosumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Latin America Burosumab Market Size by Country (2021-2026) & (US$ Million) Table 119. Latin America Burosumab Market Share by Country (2021-2026) Table 120. Latin America Burosumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Latin America Burosumab Market Share Forecast by Country (2027-2032) Table 122. Middle East and Africa Burosumab Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Middle East and Africa Burosumab Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Burosumab Sales Market Share by Country (2021-2026) Table 125. Middle East and Africa Burosumab Sales Forecast by Country (2027-2032) & (K Units) Table 126. Middle East and Africa Burosumab Sales Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Burosumab Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Burosumab Market Size by Country (2021-2026) & (US$ Million) Table 129. Middle East and Africa Burosumab Market Share by Country (2021-2026) Table 130. Middle East and Africa Burosumab Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Middle East and Africa Burosumab Market Share Forecast by Country (2027-2032) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Burosumab Distributors List Table 135. Burosumab Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Burosumab Image Figure 2. Global Burosumab Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Burosumab Market Size (2021-2032) & (US$ Million) Figure 4. Global Burosumab Sales (2021-2032) & (K Units) Figure 5. 10mg/mL Image Figure 6. Global 10mg/mL Sales YoY Growth (2021-2032) & (K Units) Figure 7. 20mg/mL Image Figure 8. Global 20mg/mL Sales YoY Growth (2021-2032) & (K Units) Figure 9. 30mg/mL Image Figure 10. Global 30mg/mL Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Burosumab Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Burosumab Market Share by Type 2025 VS 2032 Figure 13. North America Burosumab Sales Market Share in Volume by Type in 2025 Figure 14. North America Burosumab Sales Market Share in Value by Type in 2025 Figure 15. Europe Burosumab Sales Market Share in Volume by Type in 2025 Figure 16. Europe Burosumab Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Burosumab Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Burosumab Sales Market Share in Value by Type in 2025 Figure 19. Latin America Burosumab Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Burosumab Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Burosumab Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Burosumab Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Burosumab Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Minor Patients Over 1 Year Old Image Figure 26. Global Minor Patients Over 1 Year Old Sales YoY Growth (2021-2032) & (K Units) Figure 27. Adult Patients Image Figure 28. Global Adult Patients Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Burosumab Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Burosumab Market Share by Application 2025 VS 2032 Figure 31. North America Burosumab Sales Market Share in Volume by Application in 2025 Figure 32. North America Burosumab Sales Market Share in Value by Application in 2025 Figure 33. Europe Burosumab Sales Market Share in Volume by Application in 2025 Figure 34. Europe Burosumab Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Burosumab Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Burosumab Sales Market Share in Value by Application in 2025 Figure 37. Latin America Burosumab Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Burosumab Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Burosumab Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Burosumab Sales Market Share in Value by Application in 2025 Figure 41. North America Burosumab Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Burosumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Burosumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Burosumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Burosumab Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Burosumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Burosumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Burosumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Burosumab Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Burosumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Burosumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Burosumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Burosumab Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Burosumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Burosumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Burosumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Burosumab Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Burosumab Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Burosumab Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Burosumab Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Burosumab Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Burosumab Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/mL
  • 20mg/mL
  • 30mg/mL
Applications
  • Minor Patients Over 1 Year Old
  • Adult Patients
Companies covered
  • Ultragenyx
  • Kyowa Kirin Co.,Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Burosumab Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Burosumab Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Burosumab Market by Type
  6. 1.3.1 10mg/mL
  7. 1.3.2 20mg/mL
  8. 1.3.3 30mg/mL
  9. 1.4 Global Burosumab Market Size by Type
  10. 1.4.1 Global Burosumab Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Burosumab Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Burosumab Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Burosumab Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Burosumab Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Burosumab Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Burosumab Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Burosumab Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Burosumab Industry Trends
  2. 2.2 Burosumab Industry Drivers
  3. 2.3 Burosumab Industry Opportunities and Challenges
  4. 2.4 Burosumab Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Burosumab Revenue (2021-2026)
  2. 3.2 Global Top Players by Burosumab Sales (2021-2026)
  3. 3.3 Global Top Players by Burosumab Price (2021-2026)
  4. 3.4 Global Burosumab Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Burosumab Major Company Production Sites & Headquarters
  6. 3.6 Global Burosumab Company, Product Type & Application
  7. 3.7 Global Burosumab Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Burosumab Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Burosumab Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Burosumab Tier 1, Tier 2, and Tier 3
4 Burosumab Regional Status and Outlook
  1. 4.1 Global Burosumab Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Burosumab Historic Market Size by Region
  3. 4.2.1 Global Burosumab Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Burosumab Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Burosumab Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Burosumab Forecasted Market Size by Region
  7. 4.3.1 Global Burosumab Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Burosumab Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Burosumab Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Burosumab by Application
  1. 5.1 Burosumab Market by Application
  2. 5.1.1 Minor Patients Over 1 Year Old
  3. 5.1.2 Adult Patients
  4. 5.2 Global Burosumab Market Size by Application
  5. 5.2.1 Global Burosumab Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Burosumab Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Burosumab Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Burosumab Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Burosumab Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Burosumab Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Burosumab Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Burosumab Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ultragenyx
  2. 6.1.1 Ultragenyx Company Information
  3. 6.1.2 Ultragenyx Business Overview
  4. 6.1.3 Ultragenyx Burosumab Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ultragenyx Burosumab Product Portfolio
  6. 6.1.5 Ultragenyx Recent Developments
  7. 6.2 Kyowa Kirin Co.,Ltd.
  8. 6.2.1 Kyowa Kirin Co.,Ltd. Company Information
  9. 6.2.2 Kyowa Kirin Co.,Ltd. Business Overview
  10. 6.2.3 Kyowa Kirin Co.,Ltd. Burosumab Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Kyowa Kirin Co.,Ltd. Burosumab Product Portfolio
  12. 6.2.5 Kyowa Kirin Co.,Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Burosumab Sales by Country
  2. 7.1.1 North America Burosumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Burosumab Sales by Country (2021-2026)
  4. 7.1.3 North America Burosumab Sales Forecast by Country (2027-2032)
  5. 7.2 North America Burosumab Market Size by Country
  6. 7.2.1 North America Burosumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Burosumab Market Size by Country (2021-2026)
  8. 7.2.3 North America Burosumab Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Burosumab Sales by Country
  2. 8.1.1 Europe Burosumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Burosumab Sales by Country (2021-2026)
  4. 8.1.3 Europe Burosumab Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Burosumab Market Size by Country
  6. 8.2.1 Europe Burosumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Burosumab Market Size by Country (2021-2026)
  8. 8.2.3 Europe Burosumab Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Burosumab Sales by Country
  2. 9.1.1 Asia-Pacific Burosumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Burosumab Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Burosumab Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Burosumab Market Size by Country
  6. 9.2.1 Asia-Pacific Burosumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Burosumab Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Burosumab Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Burosumab Sales by Country
  2. 10.1.1 South America Burosumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Burosumab Sales by Country (2021-2026)
  4. 10.1.3 South America Burosumab Sales Forecast by Country (2027-2032)
  5. 10.2 South America Burosumab Market Size by Country
  6. 10.2.1 South America Burosumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Burosumab Market Size by Country (2021-2026)
  8. 10.2.3 South America Burosumab Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Burosumab Sales by Country
  2. 11.1.1 Middle East and Africa Burosumab Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Burosumab Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Burosumab Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Burosumab Market Size by Country
  6. 11.2.1 Middle East and Africa Burosumab Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Burosumab Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Burosumab Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Burosumab Value Chain Analysis
  2. 12.1.1 Burosumab Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Burosumab Production Mode & Process
  7. 12.2 Burosumab Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Burosumab Distributors
  10. 12.2.3 Burosumab Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst